Anna Catalanotto is a Senior Program Manager with Cardinal HealthTM Advanced Therapy Solutions, driving commercialization strategy and market access initiatives for cell and gene therapies. She works with biopharmaceutical manufacturers and academic health systems to build solutions that optimize ordering, enhance provider experience, and accelerate patient access to advanced treatments.

Before joining Cardinal Health, Anna worked in life sciences consulting, specializing in cell and gene therapy and rare disease. She advised leading biopharmaceutical companies on go-to-market strategy and market access planning, across patient, provider, and payer engagement strategies.

Anna holds a Bachelor of Science in Biology from Davidson College and is passionate about supporting patient access to innovative therapies that have the potential to redefine treatment possibilities.